19 July 2021For a small number of medicines, there are differences in equivalent doses of oral formulations of the same medicine. This needs to be considered when…
Medicine Compliance Aid Stability
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from light. Store in the original pack.
22 November 2022
Lactation Safety Information
Limited published evidence of safety
Long half-life increases risk of accumulation in breastfed infants
Unlikely to be absorbed by infant’s GI tract
Use only when other antifungals are considered inappropriate
Monitor infant for gastro-intestinal disturbances, especially if used for prolonged periods or in high doses, although unlikely to occur.
10 November 2020